Summer Intern
Takeda Development Center Americas Inc.
Mei-Chi Su is currently a 5th graduate student at University of Minnesota in Department of Experimental and Clinical Pharmacology. She earned her master's degree from National Taiwan University College of Pharmacy and majored in Pharmaceutics. She currently studies oncology pharmacogenomics and especially utilizes patients' gene expression data to predict drug responses and further repurpose existing drugs for treating advanced prostate cancer. Beyond her current research, she is also interested in developing a mathematical model to 1) understand the relationship between exposure and response and 2) identify critical factors to guide formulation developments.